US10226442B2 – March 12, 2019 – Lithium salts of N-substituted glycine compounds and uses thereof

Please complete the required fields.




Inventors :

Guochuan Emil Tsai; Ching-Hsun Huang; Han-Yi Hsieh; Jing-Jia Huang; Ching-Cheng Wang

Owner :

SYNEURX INTERNATIONAL (TAIWAN) CORP., TAIWAN

Application Number :

US15646034

Document Number :

US10226442B2

Priority Date :

July 10, 2017

Filing Date :

July 10, 2017

Date of Grant/ Publication :

March 12, 2019

Class :

A23L33 / 00; A23L33 / 16; A61K31 / 12; A61K31 / 40; A61K45 / 06; A61K31 / 198; A61K31 / 382; A61K31 / 407; A61K31 / 496; A61K31 / 519; A61K31 / 554; A61K31 / 4439; A61K31 / 5415; A61K31 / 5513

Abstract

The present invention relates to a composition comprising a lithium salt of an N-substituted glycine compound and a carrier, wherein the lithium salt of the N-substituted glycine compound is of Formula (I): in which R 1 , R 2 , and R 3 each are independently hydrogen, alkyl, alkenyl, alkynyl, aralkyl, carbocyclyl, aryl, or heteroaryl, or one of R 1 , R 2 , and R 3 is absent. Also provided in the present invention is a method of mitigating at least one symptom of a neuropsychiatric disorder, comprising administering to a subject in need thereof the lithium salt of an N-substituted glycine compound of Formula (I).

Claim(s)

1. A composition comprising a therapeutically effective or prophylactically effective amount of a lithium salt of N-methylglycine and a carrier.;
6. A method for mitigating a symptom of a neuropsychiatric disorder, comprising administering to a subject in need thereof an effective amount of a lithium salt of N-methylglycine or a composition comprising the lithium salt.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login